Projects
MHeNs is well connected in the region, as well as National and International and functions as a dedicated and innovative interface between local stakeholders, such as care organisations, knowledge institutes, governments and local health councils, citizens and researchers who work at MHeNs.
Based on needs, a research project will be developed in close consultation with the academic staff and the organisation to provide useful answers and present findings. Research projects can range from short-term projects to projects lasting for multiple years with numerous researchers.
Explore our overview of MHeNs projects:
Ongoing projects
TRADE Project
Sjacko Sobczak works as a psychiatrist in elderly care at Mondriaan and as a senior researcher at MHeNs. Her main focus as a psychiatrist is consulting in several regional nursing homes. The TRADE-project focusses on PTSD in dementia.

Parkinson's Disease Research
Maastricht University has a long history of research into Parkinson’s disease, with a special focus on the diagnosis and treatment of neuropsychiatric symptoms and the further development of deep brain stimulation.

Neuripides Project
We investigate the brain effects of deep brain stimulation with functional magnetic resonance imaging (fMRI) and use these as starting points for neurofeedback training protocols.

Youth-GEMs Project
Youth-GEMs: EU Horizon project to investigate the role of genetic and environmental factors in mental health of young people.

Muscle Stem Cell Therapy Project
UM leads the EMR consortium Generate Your Muscle (GYM), which is developing autologous stem cell therapy for genetic and non-genetic muscle disease. Modified muscle stem cells will be used to treat the muscle pathology.

STREAMLINE
STREAMLINE aims to model neurodevelopmental disorders in patient-specific genetic background stem cells by networking with internationally leading European partners in the fields of stem cell technology, ethics, and bioinformatics.

Past projects
EU-GEI project
The aim of EU-GEI was to identify, over a 5-year period, the interactive genetic, clinical and environmental determinants, involved in the development, severity and outcome of schizophrenia.
